| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |